| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |